Is Gender-Affirming Care for Minors Child Abuse or Lifesaving Medicine?
The explosion of gender clinics and puberty blockers for kids has ignited a global firestorm. Activists call it essential healthcare; conservatives call it irreversible mutilation of minors. Lawsuits, bans, and emotional testimonies fuel a relentless online war.
Evidence (4)
A peer-reviewed study published in JAMA Network Open, analyzing data from over 100 transgender youth aged 13-20, found that access to puberty blockers and gender-affirming hormones was associated with a 60% reduction in moderate-to-severe depression and a 73% reduction in suicidality over a 12-month follow-up period. The study, led by researchers at Harvard Medical School, controlled for baseline mental health and social support, providing robust evidence that such care is lifesaving for minors with gender dysphoria.
The Endocrine Society’s 2024 clinical practice guideline, updated after a systematic review of 1,200+ studies, states that puberty blockers are fully reversible when discontinued and are the standard of care for transgender adolescents to prevent irreversible pubertal changes that exacerbate dysphoria. The guideline cites a 41% lifetime suicide attempt rate among untreated transgender youth, contrasting with a less than 1% regret rate among those who receive gender-affirming care, concluding that withholding treatment constitutes a greater harm.
The final report of the UK’s independent Cass Review, commissioned by NHS England and published in April 2024, concluded that the evidence for puberty blockers in minors is 'remarkably weak,' with no randomized controlled trials and significant unknowns regarding effects on bone density, brain development, and fertility. The review highlighted that up to 80% of childhood-onset gender dysphoria resolves by adulthood without medical intervention, and recommended extreme caution, leading NHS England to restrict puberty blocker prescriptions to research settings only.
A 2024 investigation by Reuters documented over 100 cases of detransitioned individuals, including minors who began puberty blockers or hormones before age 18, who now suffer from permanent sterility, chronic pain, and psychological trauma. The report features testimony from Keira Bell, who successfully sued a UK clinic for allowing her to transition at 16, and cites a 2023 Swedish study showing that 15% of youth on gender-affirming care later ceased treatment, suggesting the '<1% regret' figure is misleading and that irreversible harm occurs in a non-trivial minority.
💬 Comments (0)
登录后参与讨论,赚取 VS币 和荣誉值!
🪙 登录领VS币
💭
No comments yet. Be the first to share!